Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Part of paid clinical trials in Fort Smith, Arkansas.
- Sponsor
- Pfizer
- Study ID
- NCT05156398
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Rimegepant — DRUGRimegepant 75mg or 50mg (2 X 25mg) ODT
- Placebo — DRUGMatching placebo 75mg or 50mg (2 X 25mg) ODT
Study Details
The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.
Key Dates
- Start date
- Feb 28, 2022
- Status verified
- Jun 2026
- Primary completion
- Nov 29, 2031
- Completion
- Nov 27, 2032
Study Design
- Enrollment
- 640 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Rimegepant / BHV3000Rimegepant 75mg or 50mg (2 X 25mg) ODT
- Placebo Comparator: Matching PlaceboMatching placebo 75mg or 50mg (2 X 25mg) ODT
Primary Outcome Measure
Change from baseline in the mean number of migraine days per month as measured over the 12-week double-blind phase of the study in adolescents with episodic migraine [ Time Frame: 3 months (12 weeks) ]
Central Contacts
- Pfizer Pfizer CT.gov Call Center1-800-718-1021
Locations (54)
Find similar trials in Fort Smith, AR
By condition
By specialty
By research site
The Belinga Clinic· Fort Smith, ARAdvanced Investigative Medicine, Inc.· Hawthorne, CAVelocity Clinical Research San Diego· La Mesa, CAColorado Springs Neurological Associates· Colorado Springs, COAdvanced Neurosciences Research, LLC· Fort Collins, COMeridian Clinical Research, LLC· Washington D.C., DC
Related Studies
- Quality Improvement and Practice Based Research in Neurology Using the EMRPHASE4 · Enrolling By Invitation · Endeavor Health · Evanston, Illinois
- Pain Biomarker StudyPHASE1 · Enrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas
- Mind Body Balance for Pediatric MigraineRecruiting · Children's Hospital Medical Center, Cincinnati · Aurora, Colorado
- Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial PainPHASE2 · Recruiting · Stanford University · Stanford, California